Paxil class action settlement
Executive Summary
A Minnesota District Court judge on Sept. 28 approved a class action settlement under which GlaxoSmithKline will pay $40 million to reimburse third party payers for costs of Paxil (paroxetine) prescribed to persons under the age of 18. Plaintiffs claimed GSK promoted Paxil for children when clinical trials showed the antidepressant had a greater risk of suicide risk than placebo. Last year GSK settled a class action involving parents who sought reimbursement for Paxil prescriptions